Anti-influenza therapies that target the host
A drug that targets the host rather than the virus could get around the problem of antiviral resistance. Every year, hundreds of thousands of people die of seasonal influenza caused by infection with influenza A and B viruses.
A drug that targets the host rather than the virus could get around the problem of antiviral resistance. Every year, hundreds of thousands of people die of seasonal influenza caused by infection with influenza A and B viruses. This story matters for Science & Discovery readers tracking engineering. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. EngineeringNews curates and briefs the science & discovery stories that matter. Our editorial policy →